Pfizer

Pfizer Inc.

Logo used since 2021
Company type	Public
Traded as	NYSE: PFE S&P 100 component S&P 500 component
Industry	Pharmaceutical Biotechnology
Founded	1849; 176 years ago (1849) in New York City
Founders	Charles Pfizer Charles F. Erhart
Headquarters	The Spiral, New York City , US
Area served	Worldwide
Key people	Albert Bourla (chairman and CEO)
Products	Pharmaceutical drugs vaccines
Revenue	US$63.6 billion (2024)
Operating income	US$10.6 billion (2024)
Net income	US$8.02 billion (2024)
Total assets	US$219.4 billion (2024)
Total equity	US$176.2 billion (2024)
Number of employees	c. 88,000 (2024)
Website	www.pfizer.com
Footnotes / references [1]

Former corporate logos (until 2021).

Pfizer Inc. (/ˈfaɪzər/ FY-zər)^[2] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis (apixaban) ($7.3 billion in 2024 revenues, 11% of total revenues), Prevnar (a pneumococcal conjugate vaccine) ($6.4 billion in 2024 revenues, 10% of total revenues), Paxlovid (Nirmatrelvir/ritonavir) ($5.7 billion in 2024 revenues, 9% of total revenues), Vyndaqel (tafamidis) ($5.4 billion in 2024 revenues, 8% of total revenues), Comirnaty (the Pfizer–BioNTech COVID-19 vaccine) ($5.3 billion in 2023 revenues, 8% of total revenues), and Ibrance (palbociclib) ($4.3 billion in 2024 revenues, 6% of total revenues).^[3] In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries.^[3]

The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 list.^[4]